| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |